Average Insider

Where insiders trade, we follow

AbCellera Biologics Inc. ($ABCL)
Booth Andrew โ€“ Chief Financial Officer
Nov 13, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$2.75
Current$11.4971.2% above low, 28.8% below high
Purchase$11.3369.9% above low, 30.1% below high
52W High$15.02
Shares
8,600
Price
$11.33
Total Value
$97,438.00
P&L
+1.4% (+$1,376.00)

Nearby Earnings

Nov 5, 2026
EPS:Est: -0.18
Revenue:Est: $6.21M
Nov 9, 2026 ๐Ÿš€
EPS:-0.13 (est: -0.17)-23.8%
Revenue:$10.64M (est: $8.42M)+26.4%

Transaction Details

InsiderBooth Andrew
TitleChief Financial Officer
Transaction DateNov 13, 2026
Transaction CodeP Purchase
Acquired/DisposedAcquired
Security
Common Shares
Direct/IndirectDirect
Filing DateNov 13, 2026
Shares Purchased8,600
Price per Share$11.33
Total Value$97,438.00
Shares Owned After491,400
DerivativeNo
Accession Number0001834411-26-000010
DocumentView SEC Filing
Version: v26.10.12